BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Crippa S, Partelli S, Belfiori G, Palucci M, Muffatti F, Adamenko O, Cardinali L, Doglioni C, Zamboni G, Falconi M. Management of neuroendocrine carcinomas of the pancreas (WHO G3): A tailored approach between proliferation and morphology. World J Gastroenterol 2016; 22(45): 9944-9953 [PMID: 28018101 DOI: 10.3748/wjg.v22.i45.9944]
URL: https://www.wjgnet.com/1007-9327/full/v22/i45/9944.htm
Number Citing Articles
1
Andrea Lania, Francesco Ferraù, Manila Rubino, Roberta Modica, Annamaria Colao, Antongiulio Faggiano. Neoadjuvant Therapy for Neuroendocrine Neoplasms: Recent Progresses and Future ApproachesFrontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.651438
2
Burcin Özdirik, Anna K. Stueven, Raphael Mohr, Lukas Geisler, Alexander Wree, Jana Knorr, Münevver Demir, Mihael Vucur, Sven H. Loosen, Fabian Benz, Markus Reiss, Bertram Wiedenmann, Frank Tacke, Henning Jann, Teresa Hellberg, Christoph Roderburg. Analysis of miR-29 Serum Levels in Patients with Neuroendocrine Tumors—Results from an Exploratory StudyJournal of Clinical Medicine 2020; 9(9): 2881 doi: 10.3390/jcm9092881
3
Newton A C S Wong, Sari Suortamo, Elinor George, Sophie Beavers. Paraduodenal/pancreatic Ewing sarcoma is very rare and therefore may be mistaken for neuroendocrine carcinomaJournal of Clinical Pathology 2022; 75(1): 71 doi: 10.1136/jclinpath-2021-207452
4
Tomoaki Hamana, Shigeru Sakurai, Atsuko Hamada, Shinnichi Sakamoto, Hisako Furusho, Shigeaki Toratani. A case of primary neuroendocrine carcinoma of the mandibular gingiva treated using multimodal therapyJournal of Oral and Maxillofacial Surgery, Medicine, and Pathology 2023; 35(1): 60 doi: 10.1016/j.ajoms.2022.07.013
5
Lingaku Lee, Tetsuhide Ito, Robert T. Jensen. Imaging of pancreatic neuroendocrine tumors: recent advances, current status, and controversiesExpert Review of Anticancer Therapy 2018; 18(9): 837 doi: 10.1080/14737140.2018.1496822
6
Martine Bocchini, Fabio Nicolini, Stefano Severi, Alberto Bongiovanni, Toni Ibrahim, Giorgia Simonetti, Ilaria Grassi, Massimiliano Mazza. Biomarkers for Pancreatic Neuroendocrine Neoplasms (PanNENs) Management—An Updated ReviewFrontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.00831
7
Tiffany J. Sinclair, George A. Poultsides. Islet TumorsAdvances in Surgery 2020; 54: 69 doi: 10.1016/j.yasu.2020.04.004
8
C Ricci, S Partelli, L Landoni, M Rinzivillo, C Ingaldi, V Andreasi, C Nessi, F Muffatti, M Fontana, D Tamburrino, G Deiro, L Alberici, D Campana, F Panzuto, C Bassi, M Falconi, R Casadei. Sporadic non-functioning pancreatic neuroendocrine tumours: multicentre analysisBritish Journal of Surgery 2021; 108(7): 811 doi: 10.1093/bjs/znaa141
9
Adele Busico, Patrick Maisonneuve, Natalie Prinzi, Sara Pusceddu, Giovanni Centonze, Giovanna Garzone, Alessio Pellegrinelli, Luca Giacomelli, Alessandro Mangogna, Cinzia Paolino, Antonino Belfiore, Ketevani Kankava, Federica Perrone, Elena Tamborini, Giancarlo Pruneri, Nicola Fazio, Massimo Milione. Gastroenteropancreatic High-Grade Neuroendocrine Neoplasms: Histology and Molecular Analysis, Two Sides of the Same CoinNeuroendocrinology 2020; 110(7-8): 616 doi: 10.1159/000503722
10
Filippo Borri, Rita Bonfiglio, Martina Mandarano. Hepato-Pancreato-Biliary Malignancies2021; : 1 doi: 10.1007/978-3-030-37482-2_37-1
11
Giovanni Guarneri, Giulia Gasparini, Stefano Crippa, Valentina Andreasi, Massimo Falconi. Diagnostic strategy with a solid pancreatic massLa Presse Médicale 2019; 48(3): e125 doi: 10.1016/j.lpm.2019.02.026
12
Tumors of the Pancreas2023; : 353 doi: 10.55418/9781933477275-12
13
Filippo Borri, Rita Bonfiglio, Martina Mandarano. Hepato-Pancreato-Biliary Malignancies2022; : 639 doi: 10.1007/978-3-030-41683-6_37
14
Bozena Smolkova, Agapi Kataki, Julie Earl, Ignacio Ruz-Caracuel, Marina Cihova, Maria Urbanova, Verona Buocikova, Sandra Tamargo, Vita Rovite, Helvijs Niedra, Joerg Schrader, Yvonne Kohl. Liquid biopsy and preclinical tools for advancing diagnosis and treatment of patients with pancreatic neuroendocrine neoplasmsCritical Reviews in Oncology/Hematology 2022; 180: 103865 doi: 10.1016/j.critrevonc.2022.103865
15
I. Pergolini, S. Crippa, M. Pagnanelli, G. Belfiori, A. Pucci, S. Partelli, C. Rubini, P. Castelli, G. Zamboni, M. Falconi. Prognostic impact of Ki‐67 proliferative index in resectable pancreatic ductal adenocarcinomaBJS Open 2019; 3(5): 646 doi: 10.1002/bjs5.50175
16
Rihong Zhang, Yu Guo, Youliang Wang, Li Hu, Cheng Fang, Yujie Yang, Xianqi Yang, Luohai Chen, Jie Chen, Wei Wang, Xiaowei Sun. Novel staging for gastric neuroendocrine neoplasms by incorporating the WHO grading into the TNM staging systemCancer Medicine 2023; 12(6): 6623 doi: 10.1002/cam4.5437
17
Akriti Pokhrel, Richard Wu, Jen Chin Wang. Review of Merkel cell carcinoma with solitary pancreatic metastases mimicking primary neuroendocrine tumor of the pancreasClinical Journal of Gastroenterology 2023; 16(5): 641 doi: 10.1007/s12328-023-01821-x
18
Maria Chiara Zatelli, Elia Guadagno, Erika Messina, Fabio Lo Calzo, Antongiulio Faggiano, Annamaria Colao, _ _. Open issues on G3 neuroendocrine neoplasms: back to the futureEndocrine-Related Cancer 2018; 25(6): R375 doi: 10.1530/ERC-17-0507
19
Burcin Özdirik, Anna Stueven, Jana Knorr, Lukas Geisler, Raphael Mohr, Münevver Demir, Teresa Hellberg, Sven H. Loosen, Fabian Benz, Bertram Wiedenmann, Frank Tacke, Alexander Wree, Henning Jann, Christoph Roderburg. Soluble Urokinase Plasminogen Activator Receptor (suPAR) Concentrations Are Elevated in Patients with Neuroendocrine MalignanciesJournal of Clinical Medicine 2020; 9(6): 1647 doi: 10.3390/jcm9061647
20
Krystallenia I. Alexandraki, Aggeliki Karapanagioti, Ioannis Karoumpalis, Georgios Boutzios, Gregory A. Kaltsas. Advances and Current Concepts in the Medical Management of Gastroenteropancreatic Neuroendocrine NeoplasmsBioMed Research International 2017; 2017: 1 doi: 10.1155/2017/9856140
21
Giuseppe Pelosi, Fabrizio Bianchi, Elisa Dama, Jasna Metovic, Marco Barella, Angelica Sonzogni, Adriana Albini, Mauro Papotti, Yulan Gong, Namrata Vijayvergia. A Subset of Large Cell Neuroendocrine Carcinomas in the Gastroenteropancreatic Tract May Evolve from Pre-existing Well-Differentiated Neuroendocrine TumorsEndocrine Pathology 2021; 32(3): 396 doi: 10.1007/s12022-020-09659-6
22
Andrea Mafficini, Aldo Scarpa. Genetics and Epigenetics of Gastroenteropancreatic Neuroendocrine NeoplasmsEndocrine Reviews 2019; 40(2): 506 doi: 10.1210/er.2018-00160
23
Florian Primavesi, Eckhard Klieser, Benno Cardini, Katharina Marsoner, Uwe Fröschl, Sabine Thalhammer, Ines Fischer, Andreas Hauer, Romana Urbas, Tobias Kiesslich, Daniel Neureiter, Matthias Zitt, Reinhold Klug, Helwig Wundsam, Franz Sellner, Josef Karner, Reinhold Függer, Fergül Cakar-Beck, Peter Kornprat, Dietmar Öfner, Stefan Stättner. Exploring the surgical landscape of pancreatic neuroendocrine neoplasia in Austria: Results from the ASSO pNEN study groupEuropean Journal of Surgical Oncology 2019; 45(2): 198 doi: 10.1016/j.ejso.2018.08.016
24
Amy Chang, Scott K. Sherman, James R. Howe, Vaibhav Sahai. Progress in the Management of Pancreatic Neuroendocrine TumorsAnnual Review of Medicine 2022; 73(1): 213 doi: 10.1146/annurev-med-042320-011248
25
Daniel M. Girardi, Andrea C.B. Silva, Juliana Florinda M. Rêgo, Renata A. Coudry, Rachel P. Riechelmann. Unraveling molecular pathways of poorly differentiated neuroendocrine carcinomas of the gastroenteropancreatic system: A systematic reviewCancer Treatment Reviews 2017; 56: 28 doi: 10.1016/j.ctrv.2017.04.002
26
Rui Mao, Kan Li, Jian-Qiang Cai, Sheng Luo, Megan Turner, Dan Blazer, Hong Zhao. Adjuvant Chemotherapy Versus Observation Following Resection for Patients With Nonmetastatic Poorly Differentiated Colorectal Neuroendocrine CarcinomasAnnals of Surgery 2021; 274(2): e126 doi: 10.1097/SLA.0000000000003562